COMPANY PROFILE

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 428953.02 Face Value (Rs.) : 10 House : Glaxosmithkline - MNC
BSECurrent Price (Rs.) 2526.70Change (Rs.)43.15 (+1.74 %)
PREV CLOSE (Rs.) 2483.55
OPEN PRICE (Rs.) 2512.05
BID PRICE (QTY) 2524.05 (1)
OFFER PRICE (QTY) 2527.80 (3)
VOLUME 2316
TODAY'S LOW / HIGH (Rs.)2512.00 2578.95
52 WK LOW / HIGH (Rs.)2088 3121.1
NSECurrent Price (Rs.) 2528.20Change (Rs.)33.9 (+1.36 %)
PREV CLOSE( Rs. ) 2494.30
OPEN PRICE (Rs.) 2494.30
BID PRICE (QTY) 2527.30 (2)
OFFER PRICE (QTY) 2528.40 (5)
VOLUME 42213
TODAY'S LOW / HIGH(Rs.) 2494.30 2583.10
52 WK LOW / HIGH (Rs.)2088.1 3120.7

Cash Flow

Select year
(Rs.in Million)
Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Profit Before Tax
1385.39
1255.19
959.80
841.49
2475.65
Adjustment
-65.25
-68.41
-45.13
-40.00
-1636.48
Changes In working Capital
-98.17
184.83
61.02
-45.75
119.87
Cash Flow after changes in Working Capital
1221.97
1371.61
975.69
755.75
959.04
Cash Flow from Operating Activities
903.30
1289.90
582.02
484.23
810.75
Cash Flow from Investing Activities
396.98
-45.80
8.71
807.85
-405.51
Cash Flow from Financing Activities
-737.08
-769.42
-561.50
-1543.32
-524.24
Net Cash Inflow / Outflow
563.20
474.68
29.23
-251.25
-119.00
Opening Cash & Cash Equivalents
538.85
64.17
34.94
286.19
405.19
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balalces frgn subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1102.05
538.85
64.17
34.94
286.19